Literature DB >> 8033571

A model for pterygium formation.

L S Kwok1, M T Coroneo.   

Abstract

The formation of a pterygium is modelled using a population balance model of corneal and limbal epithelial production. Scattered light incident at the temporal limbus is focused at the nasal limbus with a peak intensity > or = 20 times. We hypothesize that this causes a focal alteration of corneal epithelial stem cells (which play a role in maintaining a barrier between corneal and conjunctival epithelia). Normative rabbit corneal data were used. Light-induced conjunctival epithelial proliferation was implemented by amplifying normal epithelial cell production along a nasal sector of the limbal circumference. A ten-fold normal peak in stimulation was assumed at the nasal zero azimuth (3 o'clock position in the right eye) with a quadratic attenuation to zero stimulation (normal) at the circumferential limits. Adjacent points on the outer limbus were assumed to be independent generators of epithelial cells that migrated in centripetal streams into the cornea. Normalization of the attrition rate for a net surface accumulation of the proliferating cells was embedded into the computational algorithm. The localized conjunctival mass was allowed to travel the predicted distance along the surface before the final shape was computed. The result shows a wing-shaped mass with a curved leading edge (corneal side). It is proposed that the initial biologic event in pterygium pathogenesis is an alteration of limbal stem cells due to chronic ultraviolet light exposure. The concomitant breakdown of the limbal barrier and subsequent conjunctivalization of the cornea explain the shape and formation of a primary pterygium.

Entities:  

Mesh:

Year:  1994        PMID: 8033571     DOI: 10.1097/00003226-199405000-00005

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  31 in total

1.  Expression and regulation of cornified envelope proteins in human corneal epithelium.

Authors:  Louis Tong; Rosa M Corrales; Zhuo Chen; Arturo L Villarreal; Cintia S De Paiva; Roger Beuerman; De-Quan Li; Stephen C Pflugfelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-05       Impact factor: 4.799

2.  Proliferative and migratory aptitude in pterygium.

Authors:  Haiqing Bai; Yufei Teng; Lee Wong; Vishal Jhanji; Chi-Pui Pang; Gary Hin-Fai Yam
Journal:  Histochem Cell Biol       Date:  2010-10-12       Impact factor: 4.304

3.  Outdoor work and the risk of pterygia: a case-control study.

Authors:  J Khoo; S M Saw; K Banerjee; S E Chia; D Tan
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

4.  Ocular problems of young adults in rural Nigeria.

Authors:  S N Nwosu
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

5.  Capillaries in the epithelium of pterygium.

Authors:  P Seifert; W Sekundo
Journal:  Br J Ophthalmol       Date:  1998-01       Impact factor: 4.638

Review 6.  The role of heredity in pterygium development.

Authors:  Peter Anguria; James Kitinya; Sam Ntuli; Trevor Carmichael
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

7.  Peripheral hypertrophic subepithelial corneal degeneration presenting with bilateral nasal and temporal corneal changes.

Authors:  M Schargus; C Kusserow; U Schlötzer-Schrehardt; C Hofmann-Rummelt; G Schlunck; G Geerling
Journal:  Eye (Lond)       Date:  2014-10-03       Impact factor: 3.775

8.  Validity of a new comprehensive pterygia grading scale for use in clinical research and clinical trial.

Authors:  Ping Huang; Jianyan Huang; Tudor Tepelus; Jyotsna Maram; Srinivas Sadda; Olivia L Lee
Journal:  Int Ophthalmol       Date:  2017-10-27       Impact factor: 2.031

9.  Progenitor cells in healing after pterygium excision.

Authors:  Jeong Kyu Lee; Jae Chan Kim
Journal:  Yonsei Med J       Date:  2007-02-28       Impact factor: 2.759

10.  Removal of Tenon fortified by conjunctival-limbal autograft in treatment of pterygium.

Authors:  Suleyman Ciftci; Eyup Dogan; Umut Dag; Leyla Ciftci
Journal:  Int Ophthalmol       Date:  2016-09-09       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.